Skip to content
GLP-1 Decoder

Pennsylvania Medicaid GLP-1 Coverage: Wegovy, Zepbound

Not for weight loss. Pennsylvania Medicaid covers GLP-1s only for type 2 diabetes and other approved uses. Pennsylvania Medicaid stopped covering GLP-1s for overweight and obesity on January 1, 2026. Other uses are still covered with prior authorization.

For weight loss
Ended January 2026
For type 2 diabetes
Covered
Weight loss, KFF survey January 2026
Not covered

Does Pennsylvania Medicaid cover GLP-1s?

Sources: pa.gov, KFF 1 2.

A drug-by-drug look at Wegovy, Zepbound, Ozempic, and Mounjaro

GLP-1 drugs in Pennsylvania Medicaid
MedicineMain useIn Pennsylvania MedicaidEvery state
WegovyWeight lossEnded January 2026Wegovy and Medicaid
ZepboundWeight lossEnded January 2026Zepbound and Medicaid
FoundayoWeight lossEnded January 2026Not listed
SaxendaWeight lossEnded January 2026Saxenda and Medicaid
OzempicType 2 diabetesCovered for type 2 diabetesOzempic and Medicaid
MounjaroType 2 diabetesCovered for type 2 diabetesMounjaro and Medicaid
RybelsusType 2 diabetesCovered for type 2 diabetesRybelsus and Medicaid
TrulicityType 2 diabetesCovered for type 2 diabetesTrulicity and Medicaid
VictozaType 2 diabetesCovered for type 2 diabetesVictoza and Medicaid

Sources: pa.gov.

Prior authorization rules

Source: KFF.

How to check your plan

  1. Check the drug on the state list: Pennsylvania Medicaid drug list
  2. If a managed care plan runs your Medicaid, call the member number on your card.
  3. A preferred drug is approved faster, so ask your prescriber which GLP-1 is preferred.
  4. Save the approval or denial notice, because it tells you which rule applies.

Brand pages that apply in Pennsylvania

If Pennsylvania Medicaid says no

If coverage says no
MedicineLowest self-payManufacturer offer if your plan does not cover it
Wegovy$149 a monthNot listed
Zepbound$299 a month$299 a month
Foundayo$149 a monthNot listed

Sources: foundayo.lilly.com, TrumpRx, NovoCare, CMS.